Search - tctmd.com

Displaying 641 - 660 of 1054

Sort: Relevancy | Date

Spending More Won’t Necessarily Improve Acute MI Outcomes

News Daily News

Spending More Won’t Necessarily Improve Acute MI Outcomes

December 22, 2017

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

News Daily News

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

December 20, 2017

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

News Daily News

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

Yael L. Maxwell

December 07, 2017

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

News Daily News

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

December 05, 2017

News Daily News

FDA Approves EluNIR Drug-Eluting Stent

Michael O'Riordan

November 30, 2017

News Industry News

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

November 30, 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

November 14, 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

November 14, 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

Transradial Access in Primary PCI on the Upswing in the US but Still Uneven

News Daily News

Transradial Access in Primary PCI on the Upswing in the US but Still Uneven

November 10, 2017

CrossBoss First Shows Promise for Antegrade CTO PCI

News Conference News TCT 2017

CrossBoss First Shows Promise for Antegrade CTO PCI

TCT Daily Staff

November 07, 2017

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

October 31, 2017

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

Presentation TCT 2017

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu

October 31, 2017

Long-term Absorb BVS Data Continue to Disappoint

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Live From Denver: TCT 2017, Day One

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

October 30, 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

October 23, 2017

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.